Fundamental limit of alpha-synuclein pathology in gastrointestinal biopsy as a pathologic biomarker of Parkinson's disease: Comparison with surgical specimens. (November 2017)

• Record Type: Journal Article
• Authors: Shin, Chaewon; Park, Sung-Hye; Yun, Ji Young; Shin, Jung Hwan; Yang, Han-Kwang; Lee, Hyuk-Joon; Kong, Seong-Ho; Suh, Yun-Suhk; Shen, Guangxun; Kim, Yoon; Kim, Han-Joon; Jeon, Beomseok
• Is Part Of: Parkinsonism & related disorders. Volume 44(2017)
• Page Start: 73
• Page End: 78
• Publication Date: 2017-11
• Subjects: Parkinson's disease -- Alpha-synuclein -- Immunohistochemistry -- Gastrointestinal tract -- Biopsy -- Surgical specimen; Parkinson's disease -- Periodicals; Movement disorders -- Periodicals; Movement Disorders -- Periodicals; Nerve Degeneration -- Periodicals; Nervous System Diseases -- Periodicals; Parkinson Disease -- Periodicals; Tremor -- Periodicals; Parkinson, Maladie de -- Périodiques; Parkinson's disease; 616.833
• DOI: 10.1016/j.parkreldis.2017.09.001
• Languages: English
• ISSNs: 1353-8020

Abstract

Abstract: Objective: Alpha-synuclein (AS) accumulation identified by immunohistochemistry (IHC) of gastrointestinal (GI) tract biopsies is considered as a potential pathologic biomarker for Parkinson's disease (PD). We compared AS IHC findings in biopsy specimens and surgically resected full-depth specimens to examine the reliability of GI tract biopsies. Methods: We included patients with PD who had undergone operation of the GI tract for treatment of tumors. Controls were matched with age at operation, gender, and surgical resection site. We compared AS accumulation using phosphorylated AS (pAS) IHC between patients and controls, and within individuals between surgical and biopsy specimens. Results: A total of 33 patients with PD were categorized into either the stomach (N = 12) or colorectal group (N = 21). The frequency of pAS positivity in gastric surgical specimens was 58.3% (7/12) and 8.3% (1/12) in the patient and control groups, respectively ( p = 0.027). The frequency of pAS positivity in colorectal surgical specimens was identical in the patient and control group (23.8% [5/21] in each). Intriguingly, immunostaining results for biopsy specimens were not concordant with those for surgical specimens. There was no significant difference in the frequency of pAS positivity in biopsy specimens between patients and controls (9.1% [2/22] vs 18.2% [4/22]; p = 0.664). Interpretation: Our results demonstrate that AS accumulation identified via pAS IHC of GI biopsies is unreliable due to its low positive rates and poor concordance with surgical specimens, and that future studies investigating AS accumulation in the GI tract should target the stomach, rather than the colon or rectum. Highlights: Alpha-synuclein (AS) accumulation is present in GI tract in patients with PD. Phosphorylated AS (pAS) immunohistochemistry on biopsy tissue is unreliable. pAS immunohistochemistry on surgical specimens showed low positive rates. pAS positivity is more frequent in the stomach in patients with PD than controls. pAS positivity is not differed in colon or rectum between patients and controls.